Report cover image

Neuroendovascular Non-coils Market Outlook 2026-2034: Market Share, and Growth Analysis By Product (Neuroendovascular stents, Access devices, Flow diversion devices, Others), By End-User (Hospitals, Ambulatory surgical centers, Stroke centers, Others)

Publisher OG Analysis
Published Nov 11, 2025
SKU # OGAN20568620

Description

The Neuroendovascular Non-coils Market is valued at USD 1.14 billion in 2025 and is projected to grow at a CAGR of 4.5% to reach USD 1.72 billion by 2034.

Neuroendovascular Non-coils Market

The Neuroendovascular Non-coils market covers devices and tools used to treat ischemic and hemorrhagic cerebrovascular disease without detachable coils: stent retrievers, aspiration catheters and pumps, distal access and balloon guide catheters, intracranial and carotid stents, flow-diverting stents, intrasaccular flow disruptors, liquid embolics (e.g., cyanoacrylates, ethylene-vinyl alcohol copolymers), microcatheters/wires, and adjunct imaging/closure solutions. Top applications include mechanical thrombectomy for acute ischemic stroke (AIS), endoluminal reconstruction of aneurysms via flow diversion or intrasaccular devices, embolization of AVMs/AVFs, and endovascular treatment of intracranial atherosclerotic disease and cervical carotid stenosis. Trends emphasize faster, simpler reperfusion (large-bore aspiration, combined techniques), low-profile and more trackable systems for tortuous anatomy and distal/medium vessel occlusions, radial and transradial-first access, surface engineering for clot integration and anti-thrombogenicity, and AI-assisted triage to compress door-to-reperfusion time. Growth is propelled by stroke-system maturation, expanded imaging-guided time windows, broader indications (large-core, distal occlusions, ruptured/complex aneurysms), and rising neurointerventional capacity in emerging markets. Competitive dynamics pit diversified neuro majors against focused innovators; differentiation hinges on first-pass effect rates, distal navigability, lumen diameter and kink resistance, control of proximal flow with balloon guides, radiopacity, deliverability of long flow-diverter constructs, liquid embolic penetration/precison, and comprehensive portfolios that standardize trays and staff workflow. Barriers include capital and staffing for 24/7 programs, uneven reimbursement, operator learning curves, stroke triage logistics, and complication risks (hemorrhage, device migration). Overall, procurement is shifting from single devices to integrated reperfusion and aneurysm-reconstruction platforms - hardware + imaging/AI + training - validated by consistent clinical workflow and outcomes.

Neuroendovascular Non-coils Market Key Insights

Thrombectomy moves to “simple, fast, first pass”: Large-bore aspiration (direct-to-aspiration) and combined techniques (balloon guide + stent retriever) aim for higher first-pass reperfusion and fewer distal emboli; catheter trackability and column strength are make-or-break.
Medium/distal vessel solutions emerge: Low-profile stent retrievers, flexible aspiration catheters, and micro-navigation tools extend treatment beyond ICA/M1 to M2/M3 and posterior circulation, requiring atraumatic tips and superior torque control.
Flow diversion broadens aneurysm care: Braided, high-coverage devices with improved deliverability and anti-thrombotic surfaces expand to smaller vessels and challenging anatomies; long constructs and multi-device strategies demand precise sizing and wall apposition.
Intrasaccular flow disruptors gain favor: WEB-like implants simplify wide-neck bifurcation aneurysms, reducing dual-antiplatelet dependency; sizing accuracy and recanalization durability differentiate offerings.
Liquid embolics get more controllable: Lower viscosity, radiopacity tuning, and microcatheter compatibility improve AVM/AVF penetration and targeted devascularization; reliable detachment and reflux control are critical.
Access and support define success: Balloon guide catheters for proximal flow arrest, high-support distal access catheters, and radial-ready systems reduce embolization to new territories and improve clot control.
AI and workflow orchestration matter: LVO detection, perfusion automation, and transfer coordination compress onset-to-reperfusion and raise eligible case capture; vendors bundling software with devices influence protocol standardization.
Safety engineering as a feature: Atraumatic tips, soft zones, heparin-like or hydrophilic coatings, and radiopaque markers reduce vessel injury and aid precise placement; robust IFUs and training curb complications.
Economics favor platform partners: Hospitals prefer portfolios spanning aspiration, stent retrievers, flow-diverters, access, and embolics with consistent connectors, trays, and service - cutting room time and inventory.
Talent and accreditation bottlenecks: Growth depends on training pipelines, stroke-center accreditation, and reliable 24/7 staffing; vendors with proctoring, simulation, and outcomes dashboards have an edge.

Neuroendovascular Non-coils Market Reginal Analysis

North America

Mature stroke systems drive high thrombectomy utilization with emphasis on first-pass effect, radial-ready access, and AI-enabled triage/transfer. Aneurysm programs expand flow diversion and intrasaccular devices for complex and bifurcation lesions. Procurement favors comprehensive portfolios, rapid rep support, and data-sharing that documents door-to-reperfusion metrics. Reimbursement supports 24/7 programs, but staffing and angio-suite availability remain constraints.

Europe

Guideline-driven practice and cross-border referral networks emphasize evidence, cost-effectiveness, and standardized workflows. Hospitals prioritize low-profile, highly navigable systems for distal work, and flow-diverter lines with documented patency and antiplatelet management protocols. Public tenders weigh training, traceability, and sustainability (reduced kit waste). Radial access adoption grows alongside rigorous post-market surveillance.

Asia-Pacific

Rapid build-out of neurointerventional centers increases demand across aspiration, stent retrievers, and flow-diversion, with strong volume growth in China, Japan, South Korea, India, and Australia. Price–performance and local service are decisive; premium hubs adopt AI triage and advanced distal systems. Training partnerships and hub-and-spoke stroke networks expand eligibility and procedural consistency.

Middle East & Africa

Developing stroke networks and tertiary hubs prioritize scalable reperfusion kits, robust access catheters, and easy-to-use embolics. Procurement often seeks turnkey solutions - devices, imaging workflow, and training. Heat and logistics considerations elevate shelf-life and supply reliability. Growing interest in flow diversion and intrasaccular options accompanies investments in comprehensive neuro programs.

South & Central America

Urban referral centers expand thrombectomy capacity and selective aneurysm reconstruction programs. Budget variability favors versatile, proven systems with strong local distributor support and training. Transfer logistics and imaging access drive adoption of workflow software. Institutions value platform vendors who ensure stock continuity, provide proctoring, and help track outcomes as programs scale.

Neuroendovascular Non-coils Market Segmentation

By Product
  • Neuroendovascular stents
  • Access devices
  • Flow diversion devices
  • Others

    By End-User
  • Hospitals
  • Ambulatory surgical centers
  • Stroke centers
  • Others

    Key Market players

    Medtronic Neurovascular, Stryker Neurovascular, CERENOVUS (Johnson & Johnson), Penumbra Inc., MicroVention (Terumo), Balt, Phenox (Wallaby Medical), Acandis GmbH, Rapid Medical, Imperative Care, Vesalio, MicroPort NeuroTech, Perflow Medical, Anaconda Biomed, Cerus Endovascular

    Neuroendovascular Non-coils Market Analytics

    The report employs rigorous tools, including Porter’s Five Forces, value chain mapping, and scenario-based modelling, to assess supply–demand dynamics. Cross-sector influences from parent, derived, and substitute markets are evaluated to identify risks and opportunities. Trade and pricing analytics provide an up-to-date view of international flows, including leading exporters, importers, and regional price trends.Macroeconomic indicators, policy frameworks such as carbon pricing and energy security strategies, and evolving consumer behaviour are considered in forecasting scenarios. Recent deal flows, partnerships, and technology innovations are incorporated to assess their impact on future market performance.

    Neuroendovascular Non-coils Market Competitive Intelligence

    The competitive landscape is mapped through OG Analysis’ proprietary frameworks, profiling leading companies with details on business models, product portfolios, financial performance, and strategic initiatives. Key developments such as mergers & acquisitions, technology collaborations, investment inflows, and regional expansions are analyzed for their competitive impact. The report also identifies emerging players and innovative startups contributing to market disruption.Regional insights highlight the most promising investment destinations, regulatory landscapes, and evolving partnerships across energy and industrial corridors.

    Countries Covered

    • North America — Neuroendovascular Non-coils market data and outlook to 2034
      • United States
      • Canada
      • Mexico
    • Europe — Neuroendovascular Non-coils market data and outlook to 2034
      • Germany
      • United Kingdom
      • France
      • Italy
      • Spain
      • BeNeLux
      • Russia
      • Sweden
    • Asia-Pacific — Neuroendovascular Non-coils market data and outlook to 2034
      • China
      • Japan
      • India
      • South Korea
      • Australia
      • Indonesia
      • Malaysia
      • Vietnam
    • Middle East and Africa — Neuroendovascular Non-coils market data and outlook to 2034
      • Saudi Arabia
      • South Africa
      • Iran
      • UAE
      • Egypt
    • South and Central America — Neuroendovascular Non-coils market data and outlook to 2034
      • Brazil
      • Argentina
      • Chile
      • Peru

    * We can include data and analysis of additional countries on demand.

    Research Methodology

    This study combines primary inputs from industry experts across the Neuroendovascular Non-coils value chain with secondary data from associations, government publications, trade databases, and company disclosures. Proprietary modeling techniques, including data triangulation, statistical correlation, and scenario planning, are applied to deliver reliable market sizing and forecasting.

    Key Questions Addressed

  • What is the current and forecast market size of the Neuroendovascular Non-coils industry at global, regional, and country levels?
  • Which types, applications, and technologies present the highest growth potential?
  • How are supply chains adapting to geopolitical and economic shocks?
  • What role do policy frameworks, trade flows, and sustainability targets play in shaping demand?
  • Who are the leading players, and how are their strategies evolving in the face of global uncertainty?
  • Which regional “hotspots” and customer segments will outpace the market, and what go-to-market and partnership models best support entry and expansion?
  • Where are the most investable opportunities—across technology roadmaps, sustainability-linked innovation, and M&A—and what is the best segment to invest over the next 3–5 years?

    Your Key Takeaways from the Neuroendovascular Non-coils Market Report

    • Global Neuroendovascular Non-coils market size and growth projections (CAGR), 2024-2034
    • Impact of Russia-Ukraine, Israel-Palestine, and Hamas conflicts on Neuroendovascular Non-coils trade, costs, and supply chains
    • Neuroendovascular Non-coils market size, share, and outlook across 5 regions and 27 countries, 2023-2034
    • Neuroendovascular Non-coils market size, CAGR, and market share of key products, applications, and end-user verticals, 2023-2034
    • Short- and long-term Neuroendovascular Non-coils market trends, drivers, restraints, and opportunities
    • Porter’s Five Forces analysis, technological developments, and Neuroendovascular Non-coils supply chain analysis
    • Neuroendovascular Non-coils trade analysis, Neuroendovascular Non-coils market price analysis, and Neuroendovascular Non-coils supply/demand dynamics
    • Profiles of 5 leading companies—overview, key strategies, financials, and products
    • Latest Neuroendovascular Non-coils market news and developments

    • Table of Contents

    1. Table of Contents
    1.1 List of Tables
    1.2 List of Figures

    2. Global Neuroendovascular Non-coils Market Summary, 2025
    2.1 Neuroendovascular Non-coils Industry Overview
    2.1.1 Global Neuroendovascular Non-coils Market Revenues (In US$ billion)
    2.2 Neuroendovascular Non-coils Market Scope
    2.3 Research Methodology

    3. Neuroendovascular Non-coils Market Insights, 2024-2034
    3.1 Neuroendovascular Non-coils Market Drivers
    3.2 Neuroendovascular Non-coils Market Restraints
    3.3 Neuroendovascular Non-coils Market Opportunities
    3.4 Neuroendovascular Non-coils Market Challenges
    3.5 Tariff Impact on Global Neuroendovascular Non-coils Supply Chain Patterns

    4. Neuroendovascular Non-coils Market Analytics
    4.1 Neuroendovascular Non-coils Market Size and Share, Key Products, 2025 Vs 2034
    4.2 Neuroendovascular Non-coils Market Size and Share, Dominant Applications, 2025 Vs 2034
    4.3 Neuroendovascular Non-coils Market Size and Share, Leading End Uses, 2025 Vs 2034
    4.4 Neuroendovascular Non-coils Market Size and Share, High Growth Countries, 2025 Vs 2034
    4.5 Five Forces Analysis for Global Neuroendovascular Non-coils Market
    4.5.1 Neuroendovascular Non-coils Industry Attractiveness Index, 2025
    4.5.2 Neuroendovascular Non-coils Supplier Intelligence
    4.5.3 Neuroendovascular Non-coils Buyer Intelligence
    4.5.4 Neuroendovascular Non-coils Competition Intelligence
    4.5.5 Neuroendovascular Non-coils Product Alternatives and Substitutes Intelligence
    4.5.6 Neuroendovascular Non-coils Market Entry Intelligence

    5. Global Neuroendovascular Non-coils Market Statistics – Industry Revenue, Market Share, Growth Trends and Forecast by segments, to 2034
    5.1 World Neuroendovascular Non-coils Market Size, Potential and Growth Outlook, 2024- 2034 ($ billion)
    5.1 Global Neuroendovascular Non-coils Sales Outlook and CAGR Growth By Product, 2024- 2034 ($ billion)
    5.2 Global Neuroendovascular Non-coils Sales Outlook and CAGR Growth By End-User, 2024- 2034 ($ billion)
    5.3 Global Neuroendovascular Non-coils Sales Outlook and CAGR Growth By Segmentation3, 2024- 2034 ($ billion)
    5.4 Global Neuroendovascular Non-coils Market Sales Outlook and Growth by Region, 2024- 2034 ($ billion)

    6. Asia Pacific Neuroendovascular Non-coils Industry Statistics – Market Size, Share, Competition and Outlook
    6.1 Asia Pacific Neuroendovascular Non-coils Market Insights, 2025
    6.2 Asia Pacific Neuroendovascular Non-coils Market Revenue Forecast By Product, 2024- 2034 (USD billion)
    6.3 Asia Pacific Neuroendovascular Non-coils Market Revenue Forecast By End-User, 2024- 2034 (USD billion)
    6.4 Asia Pacific Neuroendovascular Non-coils Market Revenue Forecast By Segmentation3, 2024- 2034 (USD billion)
    6.5 Asia Pacific Neuroendovascular Non-coils Market Revenue Forecast by Country, 2024- 2034 (USD billion)
    6.5.1 China Neuroendovascular Non-coils Market Size, Opportunities, Growth 2024- 2034
    6.5.2 India Neuroendovascular Non-coils Market Size, Opportunities, Growth 2024- 2034
    6.5.3 Japan Neuroendovascular Non-coils Market Size, Opportunities, Growth 2024- 2034
    6.5.4 Australia Neuroendovascular Non-coils Market Size, Opportunities, Growth 2024- 2034

    7. Europe Neuroendovascular Non-coils Market Data, Penetration, and Business Prospects to 2034
    7.1 Europe Neuroendovascular Non-coils Market Key Findings, 2025
    7.2 Europe Neuroendovascular Non-coils Market Size and Percentage Breakdown By Product, 2024- 2034 (USD billion)
    7.3 Europe Neuroendovascular Non-coils Market Size and Percentage Breakdown By End-User, 2024- 2034 (USD billion)
    7.4 Europe Neuroendovascular Non-coils Market Size and Percentage Breakdown By Segmentation3, 2024- 2034 (USD billion)
    7.5 Europe Neuroendovascular Non-coils Market Size and Percentage Breakdown by Country, 2024- 2034 (USD billion)
    7.5.1 Germany Neuroendovascular Non-coils Market Size, Trends, Growth Outlook to 2034
    7.5.2 United Kingdom Neuroendovascular Non-coils Market Size, Trends, Growth Outlook to 2034
    7.5.2 France Neuroendovascular Non-coils Market Size, Trends, Growth Outlook to 2034
    7.5.2 Italy Neuroendovascular Non-coils Market Size, Trends, Growth Outlook to 2034
    7.5.2 Spain Neuroendovascular Non-coils Market Size, Trends, Growth Outlook to 2034

    8. North America Neuroendovascular Non-coils Market Size, Growth Trends, and Future Prospects to 2034
    8.1 North America Snapshot, 2025
    8.2 North America Neuroendovascular Non-coils Market Analysis and Outlook By Product, 2024- 2034 ($ billion)
    8.3 North America Neuroendovascular Non-coils Market Analysis and Outlook By End-User, 2024- 2034 ($ billion)
    8.4 North America Neuroendovascular Non-coils Market Analysis and Outlook By Segmentation3, 2024- 2034 ($ billion)
    8.5 North America Neuroendovascular Non-coils Market Analysis and Outlook by Country, 2024- 2034 ($ billion)
    8.5.1 United States Neuroendovascular Non-coils Market Size, Share, Growth Trends and Forecast, 2024- 2034
    8.5.1 Canada Neuroendovascular Non-coils Market Size, Share, Growth Trends and Forecast, 2024- 2034
    8.5.1 Mexico Neuroendovascular Non-coils Market Size, Share, Growth Trends and Forecast, 2024- 2034

    9. South and Central America Neuroendovascular Non-coils Market Drivers, Challenges, and Future Prospects
    9.1 Latin America Neuroendovascular Non-coils Market Data, 2025
    9.2 Latin America Neuroendovascular Non-coils Market Future By Product, 2024- 2034 ($ billion)
    9.3 Latin America Neuroendovascular Non-coils Market Future By End-User, 2024- 2034 ($ billion)
    9.4 Latin America Neuroendovascular Non-coils Market Future By Segmentation3, 2024- 2034 ($ billion)
    9.5 Latin America Neuroendovascular Non-coils Market Future by Country, 2024- 2034 ($ billion)
    9.5.1 Brazil Neuroendovascular Non-coils Market Size, Share and Opportunities to 2034
    9.5.2 Argentina Neuroendovascular Non-coils Market Size, Share and Opportunities to 2034

    10. Middle East Africa Neuroendovascular Non-coils Market Outlook and Growth Prospects
    10.1 Middle East Africa Overview, 2025
    10.2 Middle East Africa Neuroendovascular Non-coils Market Statistics By Product, 2024- 2034 (USD billion)
    10.3 Middle East Africa Neuroendovascular Non-coils Market Statistics By End-User, 2024- 2034 (USD billion)
    10.4 Middle East Africa Neuroendovascular Non-coils Market Statistics By Segmentation3, 2024- 2034 (USD billion)
    10.5 Middle East Africa Neuroendovascular Non-coils Market Statistics by Country, 2024- 2034 (USD billion)
    10.5.1 Middle East Neuroendovascular Non-coils Market Value, Trends, Growth Forecasts to 2034
    10.5.2 Africa Neuroendovascular Non-coils Market Value, Trends, Growth Forecasts to 2034

    11. Neuroendovascular Non-coils Market Structure and Competitive Landscape
    11.1 Key Companies in Neuroendovascular Non-coils Industry
    11.2 Neuroendovascular Non-coils Business Overview
    11.3 Neuroendovascular Non-coils Product Portfolio Analysis
    11.4 Financial Analysis
    11.5 SWOT Analysis

    12 Appendix
    12.1 Global Neuroendovascular Non-coils Market Volume (Tons)
    12.1 Global Neuroendovascular Non-coils Trade and Price Analysis
    12.2 Neuroendovascular Non-coils Parent Market and Other Relevant Analysis
    12.3 Publisher Expertise
    12.2 Neuroendovascular Non-coils Industry Report Sources and Methodology

    Pricing

    Currency Rates
    How Do Licenses Work?

    How Do Licenses Work?

    The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

    • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

    • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

    • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

    • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

    • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

    License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

    Request A Sample
    Head shot

    Questions or Comments?

    Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
    Chat Now
    Contact Us